← Back to headlines
Twist Bioscience Deemed Strong Buy After Guggenheim Lifts Price Target
Twist Bioscience Corporation is being considered a strong buy after Guggenheim raised its price target for the company's stock.
2 Jun, 13:56 — 2 Jun, 13:56
Sources
Showing 1 of 1 sources
